161 related articles for article (PubMed ID: 36131486)
1. Efficacy and safety of topical 5-fluorouracil in conjunctival intraepithelial neoplasia refractory to interferon alpha-2b.
Pérez-García P; Burgos-Blasco B; Gómez-Calleja V; Vidal-Villegas B; Méndez-Fernández R; Gegúndez-Fernández JA; Díaz-Valle D
J Oncol Pharm Pract; 2023 Jun; 29(4):975-979. PubMed ID: 36131486
[TBL] [Abstract][Full Text] [Related]
2. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
Boehm MD; Huang AJ
Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
[TBL] [Abstract][Full Text] [Related]
3. Topical interferon alpha-2B topic as the first therapeutic option in a clinical case of conjunctival intraepithelial neoplasia.
Pagán Carrasco S; Arranz Maestro D
Arch Soc Esp Oftalmol; 2017 Sep; 92(9):442-446. PubMed ID: 28292536
[TBL] [Abstract][Full Text] [Related]
4. Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b.
Kobayashi A; Yoshita T; Uchiyama K; Shirao Y; Kitagawa K; Fujisawa A; Tseng SC
Jpn J Ophthalmol; 2002; 46(2):215-7. PubMed ID: 12062230
[TBL] [Abstract][Full Text] [Related]
5. Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b.
Rocha-de-Lossada C; Alba-Linero C; Borroni D; Rachwani-Anil R; Zamorano-Martín F; Rodríguez-Calvo-de-Mora M
Rom J Ophthalmol; 2020; 64(1):62-65. PubMed ID: 32292860
[TBL] [Abstract][Full Text] [Related]
6. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
Krilis M; Tsang H; Coroneo M
Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
Schechter BA; Koreishi AF; Karp CL; Feuer W
Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant topical interferon-alpha-2b treatment in epithelial tumors of the ocular surface].
Fuchsluger TA; Hintschich C; Steuhl KP; Meller D
Ophthalmologe; 2006 Feb; 103(2):124-8. PubMed ID: 16047150
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy.
Alvarado-Castillo B; Santa Cruz-Pavlovich FJ; Gonzalez-Castillo C; Vidal-Paredes IA; Garcia-Benavides L; Rosales-Gradilla ME; Navarro-Partida J
BMC Ophthalmol; 2023 Jul; 23(1):335. PubMed ID: 37501105
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival intraepithelial neoplasia. Interferon as a rescue therapy after failure of mitomycin C.
de la Cruz Aguiló RI; Duch-Samper A; Hernández Pérez D; Marí Cotino J
Arch Soc Esp Oftalmol; 2014 Nov; 89(11):463-5. PubMed ID: 24377953
[TBL] [Abstract][Full Text] [Related]
11. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
Schechter BA; Schrier A; Nagler RS; Smith EF; Velasquez GE
Cornea; 2002 Jan; 21(1):6-11. PubMed ID: 11805499
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
Venkateswaran N; Mercado C; Galor A; Karp CL
Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
[TBL] [Abstract][Full Text] [Related]
13. [Topical interferon alfa-2b for primary treatment of conjunctiva-cornea intraepithelial neoplasia].
Pérez de Arcelus M; Aranguren M; Andonegui J
An Sist Sanit Navar; 2012; 35(1):137-41. PubMed ID: 22552136
[TBL] [Abstract][Full Text] [Related]
14. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
Karp CL; Moore JK; Rosa RH
Ophthalmology; 2001 Jun; 108(6):1093-8. PubMed ID: 11382635
[TBL] [Abstract][Full Text] [Related]
15. Treatment of conjunctival squamous neoplasias with interferon alpha 2ab.
Huerva V; Mangues I
J Fr Ophtalmol; 2008 Mar; 31(3):317-25. PubMed ID: 18404128
[TBL] [Abstract][Full Text] [Related]
16. Application of interferon alpha 2b in conjunctival intraepithelial neoplasia: predictors and prognostic factors.
Muñoz de Escalona Rojas JE; García Serrano JL; Cantero Hinojosa J; Padilla Torres JF; Bellido Muñoz RM
J Ocul Pharmacol Ther; 2014 Aug; 30(6):489-94. PubMed ID: 24749813
[TBL] [Abstract][Full Text] [Related]
17. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
Kusumesh R; Ambastha A; Sinha B; Kumar R
Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
[TBL] [Abstract][Full Text] [Related]
18. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
[TBL] [Abstract][Full Text] [Related]
20. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
Vann RR; Karp CL
Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]